MRI Findings of Epiphyseal Growth Plate in Healthy Children

OCD - Osteochondritis Dissecans Clinical Trial

Official title:

MRI Findings of Epiphyseal Growth Plate in Healthy Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03190200
• Other study ID #: ORTHOSURG-2017-25849
• Status: Completed
• Start date: January 1, 2018
• Est. completion date: July 1, 2023

Study information

• Verified date: August 2023
• Source: University of Minnesota
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of the study is to determine if by using MRI changes can be identified changes early on in the knees of young children that may be at risk for developing osteochondritis dissecans. If MRI can identify changes then better council can be offered about the risks of future activity and treatment options.

Description:

Each subject will be asked to undergo an MRI at enrollment, six,12, and 18 months. Subjects will be monitored for evidence of osteochondritis dissecans in order to determine if we can identify it and then create a treatment program to allow these children to avoid developing definitive disease

Recruitment information / eligibility

• Status: Completed
• Enrollment: 7
• Est. completion date: July 1, 2023
• Est. primary completion date: December 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 6 Years to 10 Years

Eligibility

Inclusion Criteria:

6-10-year-old children with a sibling with known OCD and 6-10-year-old children with a known OCD in the contralateral knee

Exclusion Criteria:

Unable to undergo an MRI

Related Conditions & MeSH terms

• OCD - Osteochondritis Dissecans
• Osteochondritis
• Osteochondritis Dissecans

Intervention

Device:
• MRI
No intervention - observational trial using MRI

Locations

Country	Name	City	State
United States	University of Minnesota	Minneapolis	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	OCD	The Development of Osteochondritis Dissecans is the outcome of interest	18 months